Health Care
Commentary
Pelosi’s Drug Price Controls Are Dangerous—But So Are Trump’s
The White House Council of Economic Advisors just issued a damning indictment of a House bill (H.R. 3) designed to lower drug prices. According to White House economists, the measure endorsed by Nancy Pelosi and her fellow House Democrats could prevent the development of 100 new drugs over the next ten years. ...
Sally C. Pipes
January 31, 2020
Health Care
Henry Miller Provides a Wuhan Flu Update on the nationally syndicated Lars Larson Show
Henry Miller joins the nationally syndicated Lars Larson Show to share updates and analysis on the Wuhan flu epidemic that started in China earlier this month. Miller also discusses the preparedness of the United States and other countries in dealing with epidemics.
Henry Miller, M.S., M.D.
January 30, 2020
Health Care
Sally Pipes Argues Against Medicare for All on the Jim Bohannon Show
Sally Pipes, PRI’s President, CEO, and Thomas W. Smith Fellow in Health Care Policy joins the nationally syndicated Jim Bohannon Show to explain the litany of problems with single payer health care and provide examples from her new book False Premise, False Promise: The Disastrous Reality of Medicare for All.
Sally C. Pipes
January 30, 2020
Commentary
China Catches Cold from the Wuhan Coronavirus—and the World Sneezes.
The outbreak of infections from a novel virus that appears to have originated in Central China has elicited a storm of commentary, much of it uninformed. Opinions have ranged from predictions of a worldwide apocalypse to dismissal of quarantines and “social distancing” as a kind of public relations stunt by ...
Henry Miller, M.S., M.D.
January 27, 2020
Commentary
Warren’s Medicare for All isn’t affordable for anyone
Democratic presidential candidate Elizabeth Warren has released her new road map for Medicare for All. She’s proposing a series of executive actions and bills that would transition the country to a government-run health system during her first term in the White House. Sen. Warren claims her brand of Medicare for All, once fully in place, would require $20.5 ...
Sally C. Pipes
January 27, 2020
Commentary
Doctors need a second opinion on ‘Medicare-for-all’
The American College of Physicians, the nation’s second-largest doctors group, has endorsed “Medicare-for-all.” The group, whose membership consists of 159,000 internists, claims the plan would bring a host of necessary changes to the American healthcare system. The American College of Physicians joins the American Nurses Association, the American Medical Association’s ...
Sally C. Pipes
January 27, 2020
Blog
Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs
In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Kerry Jackson
January 27, 2020
Health Care
Henry Miller Explains Spread of Wuhan Chinese Flu on the John Batchelor Show
Henry Miller, M.S., M.D. provides an update to the Chinese coronavirus, or what is being called the Wuhan flu for the Chinese city that the new strand of flu originated in. The first case of the flu was confirmed in the United States this week and the area around Wuhan, ...
Henry Miller, M.S., M.D.
January 23, 2020
Commentary
Price Controls Impose High Costs On Patients
Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Wayne Winegarden
January 23, 2020
Drug Pricing
Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News
Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...
Pacific Research Institute
January 23, 2020
Pelosi’s Drug Price Controls Are Dangerous—But So Are Trump’s
The White House Council of Economic Advisors just issued a damning indictment of a House bill (H.R. 3) designed to lower drug prices. According to White House economists, the measure endorsed by Nancy Pelosi and her fellow House Democrats could prevent the development of 100 new drugs over the next ten years. ...
Henry Miller Provides a Wuhan Flu Update on the nationally syndicated Lars Larson Show
Henry Miller joins the nationally syndicated Lars Larson Show to share updates and analysis on the Wuhan flu epidemic that started in China earlier this month. Miller also discusses the preparedness of the United States and other countries in dealing with epidemics.
Sally Pipes Argues Against Medicare for All on the Jim Bohannon Show
Sally Pipes, PRI’s President, CEO, and Thomas W. Smith Fellow in Health Care Policy joins the nationally syndicated Jim Bohannon Show to explain the litany of problems with single payer health care and provide examples from her new book False Premise, False Promise: The Disastrous Reality of Medicare for All.
China Catches Cold from the Wuhan Coronavirus—and the World Sneezes.
The outbreak of infections from a novel virus that appears to have originated in Central China has elicited a storm of commentary, much of it uninformed. Opinions have ranged from predictions of a worldwide apocalypse to dismissal of quarantines and “social distancing” as a kind of public relations stunt by ...
Warren’s Medicare for All isn’t affordable for anyone
Democratic presidential candidate Elizabeth Warren has released her new road map for Medicare for All. She’s proposing a series of executive actions and bills that would transition the country to a government-run health system during her first term in the White House. Sen. Warren claims her brand of Medicare for All, once fully in place, would require $20.5 ...
Doctors need a second opinion on ‘Medicare-for-all’
The American College of Physicians, the nation’s second-largest doctors group, has endorsed “Medicare-for-all.” The group, whose membership consists of 159,000 internists, claims the plan would bring a host of necessary changes to the American healthcare system. The American College of Physicians joins the American Nurses Association, the American Medical Association’s ...
Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs
In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Henry Miller Explains Spread of Wuhan Chinese Flu on the John Batchelor Show
Henry Miller, M.S., M.D. provides an update to the Chinese coronavirus, or what is being called the Wuhan flu for the Chinese city that the new strand of flu originated in. The first case of the flu was confirmed in the United States this week and the area around Wuhan, ...
Price Controls Impose High Costs On Patients
Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News
Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...